Clinical Trial Update: Safety and Efficacy of Intravenous IDOV-SAFETM in Patients With Advanced Solid Tumors [EARLY_Phase 1]

View source ↗

Summary

Clinical trial update describing a Phase 1 study of Intravenous IDOV-SAFETM in patients with advanced solid tumors, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• IDOV-SAFETM

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Neoplasms | EARLY_Phase 1 | Status: RECRUITING